| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| EMBC | EMBECTA CORP | A | C | $532.98M | 59,219,854 | 96.52% | 3.48% | Net Selling | |
| HLF | HERBALIFE LTD | B | D | $1.63B | 103,365,565 | 18.85% | 81.15% | Net Selling | Net Selling |
| IRWD | IRONWOOD PHARMACEUTICALS INC | B | B | $600.05M | 163,058,316 | 70.54% | 29.46% | Net Selling | Net Selling |
| VNT | VONTIER CORP | B | C | $5.35B | 141,600,000 | 98.95% | 1.05% | Net Selling | Net Selling |
| CCSI | CONSENSUS CLOUD SOLUTIONS INC | B | B | $564.94M | 18,868,935 | 86.34% | 13.66% | Net Selling | Net Selling |
| KEP | KOREA ELECTRIC POWER CORP | B | C | $20.99B | 641,964,077 | 3.58% | 0.00% | ||
| PBI | PITNEY BOWES INC | B | C | $1.57B | 149,942,698 | 83.93% | 9.59% | Net Selling | Net Selling |
| JILL | JJILL INC | B | B | $236.56M | 15,115,353 | 25.23% | 74.77% | Net Buying | Net Selling |
| BHC | BAUSCH HEALTH COMPANIES INC | B | C | $2.01B | 370,562,428 | 49.99% | 50.01% | Net Buying | Net Selling |
| NEXA | NEXA RESOURCES SA | A | B | $1.55B | 132,438,611 | 6.70% | 0.00% | ||
| EXEL | EXELIXIS INC | A | B | $10.84B | 259,708,689 | 94.72% | 5.28% | Net Selling | Net Selling |
| INCY | INCYTE CORP | B | D | $18.84B | 199,014,486 | 77.98% | 22.02% | Net Selling | Net Selling |
| NMM | NAVIOS MARITIME PARTNERS LP | B | A | $1.80B | 28,738,538 | 32.02% | 0.00% | ||
| AUNA | AUNA SA | A | B | $384.65M | 73,970,299 | 6.58% | 0.00% | ||
| M | MACY's INC | A | B | $4.64B | 265,883,109 | 88.59% | 1.48% | Net Selling | Net Selling |
| IMPP | IMPERIAL PETROLEUM INC/MARSHALL ISLANDS | B | B | $182.76M | 38,075,190 | 41.77% | 0.00% | ||
| RIGL | RIGEL PHARMACEUTICALS INC | B | B | $503.39M | 18,473,130 | 39.34% | 60.66% | Net Selling | Net Selling |
| GTM | ZOOMINFO TECHNOLOGIES INC | B | C | $1.92B | 305,294,644 | 60.90% | 39.10% | Net Selling | Net Selling |
| COLL | COLLEGIUM PHARMACEUTICAL INC | B | D | $1.13B | 31,753,211 | 51.96% | 48.04% | Net Selling | Net Selling |
| AREN | ARENA GROUP HOLDINGS INC | B | C | $141.92M | 47,465,749 | 3.40% | 96.60% | Net Selling | |
| VEON | VEON LTD | B | B | $3.68B | 1,728,844,934 | 1.00% | 0.00% | ||
| USNA | USANA HEALTH SCIENCES INC | B | A | $321.93M | 18,280,857 | 18.44% | 81.56% | Net Selling | Net Selling |
| PRGS | PROGRESS SOFTWARE CORP | B | B | $1.53B | 42,113,648 | 83.51% | 16.49% | Net Selling | Net Selling |
| MSGM | MOTORSPORT GAMES INC | A | C | $22.59M | 5,778,450 | 4.02% | 50.77% | Net Selling | Net Selling |
| EVER | EVERQUOTE INC | B | B | $571.43M | 36,029,683 | 59.43% | 40.57% | Net Selling | Net Selling |
| REPX | RILEY EXPLORATION PERMIAN INC | B | B | $718.20M | 21,567,428 | 13.78% | 86.22% | Net Selling | Net Selling |
| VLGEA | VILLAGE SUPER MARKET INC | A | C | $590.08M | 14,751,970 | 45.87% | 20.00% | Net Selling | |
| OTEX | OPEN TEXT CORP | B | C | $6.01B | 250,602,777 | 73.77% | 0.00% | ||
| CARS | CARSCOM INC | B | F | $446.81M | 58,636,763 | 94.65% | 5.35% | Net Selling | Net Selling |
| AFYA | AFYA LTD | B | C | $1.30B | 93,722,831 | 12.60% | 0.00% | ||
| AUDC | AUDIOCODES LTD | B | B | $223.73M | 27,418,000 | 35.86% | 0.51% | ||
| FIVN | FIVE9 INC | A | C | $1.28B | 76,495,680 | 69.07% | 30.93% | Net Selling | Net Buying |
| PD | PAGERDUTY INC | B | B | $676.40M | 91,776,804 | 65.50% | 34.50% | Net Selling | Net Selling |
| FMS | FRESENIUS MEDICAL CARE AG | A | C | $12.71B | 279,288,885 | 13.43% | 0.00% | ||
| CPRX | CATALYST PHARMACEUTICALS INC | B | A | $2.98B | 122,123,884 | 84.21% | 15.79% | Net Selling | |
| ERO | ERO COPPER CORP | B | D | $2.92B | 104,192,288 | 63.39% | 0.00% | ||
| INVA | INNOVIVA INC | A | C | $1.66B | 74,073,646 | 60.21% | 39.79% | Net Buying | Net Selling |
| PRG | PROG HOLDINGS INC | B | B | $1.18B | 39,575,810 | 57.36% | 42.64% | Net Buying | Net Selling |
| NRDS | NERDWALLET INC | A | B | $711.94M | 66,785,798 | 43.96% | 52.60% | Net Selling | Net Selling |
| PCRX | PACIRA BIOSCIENCES INC | B | F | $982.18M | 43,021,275 | 66.69% | 33.31% | Net Selling | Net Selling |
| INGM | INGRAM MICRO HOLDING CORP | A | C | $5.29B | 235,074,694 | 36.59% | 63.41% | Net Selling | Net Selling |
| KNOP | KNOT OFFSHORE PARTNERS LP | B | B | $359.33M | 33,899,000 | 24.17% | 0.00% | ||
| AVNW | AVIAT NETWORKS INC | B | C | $335.46M | 12,902,310 | 69.14% | 30.86% | Net Selling | Net Buying |
| RNG | RINGCENTRAL INC | A | C | $3.27B | 84,072,571 | 89.27% | 10.73% | Net Selling | Net Selling |
| OPY | OPPENHEIMER HOLDINGS INC | A | C | $908.72M | 10,707,255 | 37.92% | 52.38% | Net Selling | Net Selling |
| TASK | TASKUS INC | B | C | $967.19M | 90,561,252 | 29.26% | 25.77% | Net Selling | Net Selling |
| CI | CIGNA GROUP | B | C | $68.75B | 263,528,277 | 89.27% | 1.69% | Net Selling | Net Selling |
| BCRX | BIOCRYST PHARMACEUTICALS INC | A | C | $2.13B | 250,800,620 | 83.18% | 15.21% | Net Selling | Net Selling |
| AYI | ACUITY INC (DE) | B | C | $8.15B | 30,662,621 | 95.12% | 3.64% | Net Selling | Net Selling |
| TEX | TEREX CORP | B | D | $7.11B | 113,700,000 | 63.22% | 12.22% | Net Selling | Net Selling |
| OSK | OSHKOSH CORP | B | D | $9.53B | 62,548,631 | 95.35% | 4.65% | Net Buying | Net Buying |
| BTG | B2GOLD CORP | B | F | $7.04B | 1,340,622,000 | 58.60% | 0.00% | ||
| NBIX | NEUROCRINE BIOSCIENCES INC | B | D | $13.00B | 100,363,463 | 71.20% | 28.80% | Net Selling | Net Selling |
| PBYI | PUMA BIOTECHNOLOGY INC | B | C | $305.26M | 50,876,487 | 61.74% | 38.26% | Net Selling | Net Selling |
| CMCL | CALEDONIA MINING CORP PLC | A | C | $506.30M | 19,294,784 | 38.30% | 0.00% | ||
| GTEC | GREENLAND TECHNOLOGIES HOLDING CORP | A | C | $12.54M | 17,394,226 | 2.31% | 38.25% | Net Buying | |
| IBEX | IBEX LTD | A | B | $392.78M | 13,405,520 | 54.37% | 45.63% | Net Selling | Net Selling |
| UPWK | UPWORK INC | B | C | $1.62B | 130,380,213 | 60.83% | 39.17% | Net Selling | Net Selling |
| TDC | TERADATA CORP | A | B | $2.52B | 92,200,000 | 85.38% | 14.62% | Net Selling | Net Selling |
| DXC | DXC TECHNOLOGY CO | B | C | $2.09B | 169,759,963 | 94.05% | 4.62% | Net Selling | Net Buying |
| GILD | GILEAD SCIENCES INC | A | C | $181.25B | 1,241,420,528 | 87.89% | 1.12% | Net Selling | Net Selling |
| BFH | BREAD FINANCIAL HOLDINGS INC | B | B | $3.19B | 43,115,116 | 16.29% | 83.71% | Net Selling | Net Selling |
| HAE | HAEMONETICS CORP | B | B | $2.82B | 46,471,350 | 97.07% | 2.93% | Net Selling | |
| PAHC | PHIBRO ANIMAL HEALTH CORP | A | A | $2.03B | 40,534,716 | 43.28% | 56.72% | Net Selling | Net Selling |
| BMY | BRISTOL MYERS SQUIBB CO | A | C | $122.15B | 2,036,473,705 | 80.49% | 0.37% | Net Selling | Net Selling |
| MTCH | MATCH GROUP INC | B | B | $7.12B | 232,644,477 | 77.22% | 22.78% | Net Selling | Net Selling |
| TXT | TEXTRON INC | B | C | $16.24B | 174,162,437 | 89.34% | 1.76% | Net Selling | Net Selling |
| PENG | PENGUIN SOLUTIONS INC | B | C | $971.31M | 52,560,157 | 65.68% | 34.32% | Net Selling | Net Selling |
| GASS | STEALTHGAS INC | B | A | $343.42M | 36,111,888 | 38.39% | 30.00% | ||
| COHN | COHEN & CO INC | A | C | $44.05M | 2,448,559 | 0.31% | 99.69% | Net Selling | Net Selling |
| KTB | KONTOOR BRANDS INC | B | C | $3.67B | 55,254,141 | 97.26% | 2.74% | Net Selling | Net Selling |
| SBH | SALLY BEAUTY HOLDINGS INC | B | C | $1.45B | 97,008,814 | 77.54% | 22.46% | Net Selling | |
| EXPE | EXPEDIA GROUP INC | A | B | $28.23B | 122,534,873 | 63.39% | 36.61% | Net Selling | Net Selling |
| SLDE | SLIDE INSURANCE HOLDINGS INC | B | A | $2.14B | 124,319,406 | 33.54% | 48.73% | Net Selling | Net Selling |
| ENS | ENERSYS | B | C | $5.98B | 36,851,374 | 48.71% | 51.29% | Net Buying | Net Selling |
| BTMD | BIOTE CORP | B | B | $78.54M | 45,662,630 | 26.91% | 73.09% | Net Buying | |
| UHS | UNIVERSAL HEALTH SERVICES INC | B | C | $11.38B | 61,086,640 | 83.56% | 12.11% | Net Buying | |
| UGP | ULTRAPAR HOLDINGS INC | B | C | $5.66B | 1,082,072,593 | 5.70% | 0.00% | ||
| GEN | GEN DIGITAL INC | B | C | $12.86B | 605,663,774 | 84.54% | 15.46% | Net Selling | Net Buying |
| HRTG | HERITAGE INSURANCE HOLDINGS INC | B | B | $828.43M | 30,911,435 | 61.55% | 19.90% | Net Selling | Net Selling |
| PHIN | PHINIA INC | A | C | $2.46B | 37,915,162 | 97.85% | 2.15% | Net Selling | Net Selling |
| CRUS | CIRRUS LOGIC INC | B | B | $6.91B | 51,007,389 | 96.90% | 3.10% | Net Selling | Net Selling |
| CCL | CARNIVAL CORP | B | C | $37.01B | 1,425,193,296 | 63.50% | 27.52% | Net Selling | Net Selling |
| RM | REGIONAL MANAGEMENT CORP | B | C | $300.89M | 9,396,929 | 43.96% | 56.04% | Net Selling | Net Selling |
| TTEC | TTEC HOLDINGS INC | B | C | $129.67M | 48,565,548 | 16.14% | 83.86% | Net Buying | Net Buying |
| ANIP | ANI PHARMACEUTICALS INC | A | C | $1.71B | 22,424,968 | 30.60% | 69.40% | Net Selling | Net Selling |
| PCB | PCB BANCORP | B | B | $307.89M | 14,260,754 | 39.78% | 25.92% | Net Buying | Net Buying |
| BDC | BELDEN INC | B | C | $4.78B | 38,748,995 | 94.63% | 5.37% | Net Selling | Net Selling |
| QUAD | QUAD/GRAPHICS INC | A | C | $348.60M | 52,263,773 | 41.00% | 20.87% | Net Selling | Net Selling |
| GEHC | GE HEALTHCARE TECHNOLOGIES INC | B | C | $33.11B | 455,749,767 | 88.64% | 7.47% | Net Selling | Net Selling |
| VTOL | BRISTOW GROUP INC | B | D | $1.31B | 29,191,000 | 66.45% | 33.55% | Net Selling | Net Selling |
| CNMD | CONMED CORP | A | C | $1.18B | 30,833,536 | 97.18% | 2.82% | Net Selling | Net Buying |
| SON | SONOCO PRODUCTS CO | B | C | $5.24B | 98,644,015 | 87.36% | 4.53% | Net Buying | Net Selling |
| UPBD | UPBOUND GROUP INC | B | C | $1.06B | 58,117,605 | 79.91% | 20.09% | Net Buying | Net Buying |
| VVX | V2X INC | A | B | $2.19B | 31,173,445 | 94.44% | 5.56% | Net Selling | Net Selling |
| PMTS | CPI CARD GROUP INC | A | C | $183.94M | 11,460,436 | 15.84% | 84.16% | Net Selling | |
| ECPG | ENCORE CAPITAL GROUP INC | A | B | $1.44B | 21,410,273 | 30.40% | 69.60% | Net Buying | Net Selling |
| MD | PEDIATRIX MEDICAL GROUP INC | A | C | $1.64B | 83,001,072 | 94.44% | 5.56% | Net Selling | Net Selling |
| KT | KT CORP | A | C | $10.85B | 245,832,946 | 57.75% | 0.00% | ||
| CXM | SPRINKLR INC | B | C | $1.47B | 246,686,136 | 44.61% | 55.39% | Net Selling | Net Selling |
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Value stocks represent the opportunity to buy shares of solid, reliable companies at a great price.
Traditionally, value stocks are associated with large, established companies trading at lower valuations relative to fundamentals. These companies typically have strong financials but may be temporarily undervalued due to things like market sentiment, a reaction to recent earnings, or economic cycles.
However, you shouldn't just buy stocks because they look "cheap." What appear to be the best value stocks right now based on stock price alone might not have staying power. Locating high-quality value stocks for the long term requires research and due diligence.
Keep reading to learn:
Before we dive in, let’s take a step back and discuss what makes a stock a “value stock” and why some stocks trade at a discount in the first place.
A value stock is a stock that appears undervalued based on fundamental metrics such as the price-to-earnings (P/E) ratio, price-to-book (P/B) ratio, or dividend yield.
For example, if a company’s book value is $50 per share, calculated by dividing its market capitalization by outstanding shares, but the stock trades at $45, analysts may see it as a value opportunity.
Value stocks are typically associated with high quality companies with stable earnings growth. Many, but not all, value stocks pay dividends. This is in contrast to growth stocks, which aim for rapid expansion and earnings growth and to outperform the market or their industry or sector.
Value stocks also typically have lower potential returns but experience less volatility than growth stocks. Value investors buy stocks expecting their price to rise as the market recognizes their true value.
Here are some of the most common metrics used to determine whether a stock is overvalued, fairly valued, or undervalued:
However, that leads to an important point — simply relying on traditional value metrics may not be enough to identify the best opportunities. That brings us to important considerations you should know about value stocks…
1. Classic Value Metrics May Not Be Enough
The stock market has changed in the past few years. Experienced portfolio managers no longer make the majority of decisions or even buy stocks. Algorithmic trading now dominates Wall Street, with most institutional trades executed by quantitative models.
Early on, these models leveraged traditional value metrics such as price-to-earnings (P/E), book value, PEG ratio, and dividend yield if the company pays dividends. However, after years of relentless high-volume trading, the effectiveness of individual value metrics has diminished.
The real edge now comes from combining multiple factors to maximize the probability of success — just like the 21 Value metrics built into our proprietary Zen Ratings model.
Each of these 21 Value metrics has been rigorously tested and shown to identify stocks that consistently outperform the stock market and have ample room to grow. While the advantage of any single metric may be small, stacking 21 independent value criteria together significantly strengthens the odds of long-term outperformance. These include:
2. Avoid Value Traps
Many investors get so focused on specific value metrics like a low P/E ratio that they’re blinded to major red flags.
Stocks with a low P/E ratio can be appealing, but it’s important to consider why it’s so low. Value traps occur when investors fail to recognize that a low P/E may signal a deteriorating earnings outlook. It can be a sign that a company is on a downward trajectory.
The best way to avoid value traps? Look at more than just value to ensure that you invest in financially strong, growing companies.
Zen Ratings helps you look at value and beyond in stocks by evaluating 26 financial strength factors and 22 growth factors. Companies that earn A or B ratings in these categories provide strong evidence of sound, solid fundamentals throughout.
By taking this comprehensive approach, the odds of selecting companies with improving earnings prospects increase significantly, leading to more earnings beats and higher stock prices.
3. Lack of Timeliness
Value investing is considered a contrarian investing style because in essence, you are betting on companies that are currently out of favor on Wall Street.
Unfortunately, that can take time, and it can hinder your return on investment (ROI).
Happily, Zen Ratings can help you gain a bigger-picture view. In addition to 21 Value Factors, it also zeroes in on 23 different factors that greatly increase the timeliness and ROI of your stocks — namely, 22 Momentum Factors and one AI Factor.
Our Momentum models review a combination of short-term, medium-term, and long-term measures of positive price action that increase the odds the stock will stay in favor. Our Artificial Intelligence factor employs sophisticated cross-validation techniques, functioning as an internal system of checks and balances to ensure it isn't just fine-tuned for past performance but remains adaptable to future market conditions.
This approach prevents overfitting, meaning the AI doesn’t just excel in specific historical scenarios — it learns to recognize patterns that apply across various market environments, enhancing its long-term reliability.
For long-term investors, locating great value stocks requires a big-picture approach — and perhaps counterintuitively, the ability to look beyond just the intrinsic value alone. That’s because valuation is only one aspect of a stock’s bigger picture.
Yes, value investors — or really, anyone who doesn’t want to overpay for stocks — should attempt to select not only stocks that have an overall A or B Zen Rating but those with an A or B Value rating. Our Best Value Stocks to Buy Now Screener can help you quickly sift through the stocks with the highest Value ratings.
However, our Zen Ratings system allows you to look at more than just value. In addition to seeing how a stock fares for Value, you can also see its prospects for Growth, Financials, Momentum, AI, and more.
And if you’re struggling to locate Strong Buy value stocks? Our Zen Investor portfolio includes hand-selected stock picks that all have A or B Zen Ratings — A-rated stocks have historically generated an average return of 32.52%, while B-rated stocks have historically generated 19.88% returns. Gain access to the market-beating Zen Investor portfolio now.